Koyfin Home > Directory > Health Care > Aerie Pharmaceuticals > Return on Capital %

Aerie Pharmaceuticals Return on Capital % Chart (AERI)

Aerie Pharmaceuticals annual/quarterly Return on Capital % from 2013 to 2020.
  • Aerie Pharmaceuticals Return on Capital % for the quarter ending June 06, 2020 was -33.13 a -11.73% increase of 3.89 year over year
  • Aerie Pharmaceuticals Return on Capital % for the last 12 months ending June 06, 2020 was -46.88 a 25.64% decrease of -12.02 year over year
  • Aerie Pharmaceuticals Annual Return on Capital % for 2019 was -39.00 a -37.99% increase of 14.81 from 2018
  • Aerie Pharmaceuticals Annual Return on Capital % for 2018 was -53.81 a 30.69% decrease of -16.51 from 2017
  • Aerie Pharmaceuticals Annual Return on Capital % for 2017 was -37.29 a 12.46% decrease of -4.65 from 2016
Other Margins & Efficiency Metrics:
  • Aerie Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -147.39 a -7.71% increase of 11.36 year over year
View Chart On Koyfin

Quarterly AERI Return on Capital % Data

06/2020-33.13
03/2020-30.91
12/2019-31.85
09/2019-37.01
06/2019-60.04
03/2019-55.09
12/2018-52.30
09/2018-52.21
06/2018-41.00
03/2018-32.92

Annual AERI Return on Capital % Data

2019-39.00
2018-53.81
2017-37.29
2016-32.65
2015-32.04
2014-28.66
2013-40.31
2012-123.09